Outcome of etoposide and mitoxantrone for relapsed or refractory acute myeloid leukemia (RR-AML) in the modern era.

被引：0
|
作者：
Bowman, Zelia Ramone Karema
Caddell, Ryan James
Kanate, Abraham Sebastian
Shillingburg, Alex
Shah, Nilay Arvind
Craig, Michael
Cumpston, Aaron
机构：
[1] West Virginia Univ, Robert C Byrd Hlth Sci Ctr, Morgantown, WV USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] West Virginia Univ, Morgantown, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18515
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia
    Dahl, GV
    Lacayo, NJ
    Brophy, N
    Dunussi-Joannopoulos, K
    Weinstein, HJ
    Chang, MR
    Sikic, BI
    Arceci, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1867 - 1875
  • [32] A Phase 1 Study of Lenalidomide in Combination with Mitoxantrone, Etoposide, and Ara-C in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    DeAngelo, Daniel J.
    Fathi, Amir T.
    Werner, Lillian
    Avigan, David
    Luptakova, Katarina
    Wadleigh, Martha
    Steensma, David P.
    Hobbs, Gabriela Soriano
    Attar, Eyal C.
    Amrein, Philip C.
    Stone, Richard M.
    Ballen, Karen K.
    BLOOD, 2015, 126 (23)
  • [33] MITOXANTRONE, ETOPOSIDE AND CYTARABINE (MEC) CAN INDUCE DEEP COMPLETE REMISSION AND IS AN EFFECTIVE BRIDGE THERAPY TO ALLOTRANSPLANTATION (SCT) IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Marconi, G.
    Talami, A.
    Abbenante, M. C.
    Paolini, S.
    Sartor, C.
    Parisi, S.
    De Polo, S.
    Nanni, J.
    Bertamini, L.
    Ragaini, S.
    Olivi, M.
    Fontana, M. C.
    Bochicchio, M. T.
    Ottaviani, E.
    Baldazzi, C.
    Testoni, N.
    Martinelli, G.
    Cavo, M.
    Papayannidisdegrees, C.
    Curti, A.
    HAEMATOLOGICA, 2019, 104 : 134 - 134
  • [34] Mitoxantrone, Etoposide and Cytarabine (MEC) Can Induce Deep Complete Remission and Is an Effective Bridge Therapy to Allotransplantation (SCT) in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
    Marconi, Giovanni
    Talami, Annalisa
    Abbenante, Maria Chiara
    Paolini, Stefania
    Sartor, Chiara
    Parisi, Sarah
    de Polo, Stefano
    Nanni, Jacopo
    Bertamini, Luca
    Ragaini, Simone
    Olivi, Matteo
    Fontana, Maria Chiara
    Bochicchio, Maria Teresa
    Ottaviani, Emanuela
    Baldazzi, Carmen
    Testoni, Nicoletta
    Martinelli, Giovanni
    Cavo, Michele
    Papayannidis, Cristina
    Curti, Antonio
    BLOOD, 2018, 132
  • [35] Mitoxantrone and etoposide for acute myeloid leukemia in first relapse
    Im, Annie P.
    McLaughlin, Brian Thomas
    Lin, Yan
    Raptis, Anastasios
    Agha, Mounzer E.
    Hou, Jing-Zhou
    Redner, Robert
    Boyiadzis, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia
    Abbi, Kamal K. S.
    Rybka, Witold
    Ehmann, W. Christopher
    Claxton, David F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (01): : 41 - 46
  • [37] Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia
    Yamamoto, Chihiro
    Ito, Shoko
    Mashima, Kiyomi
    Umino, Kento
    Minakata, Daisuke
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Nakano, Hirofumi
    Ashizawa, Masahiro
    Okazuka, Kiyoshi
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Lekuni
    Fujiwara, Shin-Ichiro
    Ohmine, Ken
    Suzuki, Takahiro
    Muroi, Kazuo
    Kanda, Yoshinobu
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2541 - 2547
  • [38] High Dose Cytarabine, Mitoxantrone and L-Asparaginase (HAMA) Salvage For Relapsed Or Refractory Acute Myeloid Leukemia (AML) In The Elderly
    Ahmed, Tamjeed
    Holwerda, Scott
    Pardee, Timothy
    Isom, Scott
    Lyerly, Susan
    Ellis, Leslie Renee
    Manuel, Megan
    Dralle, Sarah
    Dmitriy, Berenzon
    Klepin, Heidi D.
    Powell, Bayard L.
    BLOOD, 2013, 122 (21)
  • [39] High dose cytarabine, mitoxantrone and L-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
    Ahmed, Tamjeed
    Holwerda, Scott
    Klepin, Heidi D.
    Isom, Scott
    Ellis, Leslie R.
    Lyerly, Susan
    Manuel, Megan
    Dralle, Sarah
    Berenzon, Dmitriy
    Powell, Bayard L.
    Pardee, Timothy S.
    LEUKEMIA RESEARCH, 2015, 39 (09) : 945 - 949
  • [40] Pembrolizumab and decitabine for relapsed and refractory acute myeloid leukemia (PD-AML)
    Lai, Catherine
    Karolyn, Oetjen
    Lindblad, Katherine
    Destefano, Christin
    Goswami, Meghali
    Wong, Hong Yuen
    Intrater, Therese
    Draper, Debbie
    Dillon, Laura
    Hourigan, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345